Skip to content
South Beach LongevityScience · Optimization · Longevity
Illustration representing Amino-Acid Nutrition
SBL science article58 min read

Amino-Acid Nutrition

Amino acids and derivatives. A research review published by South Beach Longevity.

Research context only. This article does not provide diagnosis, prescribing, individualized dosing, or treatment advice. Study parameters are reported as evidence, not recommendations.
How to read this document

Evidence is labelled by study type in the sentence that reports it. In vitro means a cell or a reconstituted system. Animal names the species. Human means people. A quantity appears only as it was studied, with the population and duration attached. Acute muscle-protein-synthesis (MPS) responses are not treated as hypertrophy. Rodent longevity is not treated as a human outcome. Dietary protein is not treated as isolated-amino-acid supplementation.

Findings are graded in place as established, strongly supported, emerging, plausible, or speculative. Conflict is presented as conflict. No human use, dose, route or schedule is recommended anywhere in this document.

Abstract

The twenty proteinogenic amino acids are not interchangeable nutrients. Nine are indispensable in healthy adults; several more become conditionally indispensable in growth, pregnancy, or catabolic illness; the remainder can be made from other carbon skeletons if nitrogen is available. After a meal, a large and amino-acid-specific fraction is extracted by the splanchnic bed before any peripheral tissue sees it. What remains is used for protein synthesis, transaminated, oxidised, or converted to urea. Those fates are regulated by energy status, protein status, and amino-acid sensing systems of which mTORC1 is the most discussed and the most over-read.

Human indispensable-amino-acid requirements were first estimated by nitrogen balance and later re-estimated by indicator amino-acid oxidation. The two methods do not always agree, and neither is a hypertrophy prescription. Protein quality scores — PDCAAS and DIAAS — rank foods by digestible indispensable amino acids; they do not rank supplements. Isolated leucine and branched-chain amino acids can raise acute MPS when other indispensable amino acids are present and the subject is not already protein-replete; they have not been shown, in adequately protein-controlled human trials, to be a reliable route to long-term muscle gain. Methionine restriction extends life in rodents. That finding has not been converted into a human longevity intervention. Glutamine is a major fuel of the gut and immune cells; high-dose glutamine in the critically ill produced harm in a large randomised trial. The recurring error is mechanistic extrapolation: from a kinase, a rodent cage, or a four-hour tracer infusion to a year of human outcome.

Part OneTwenty monomers, not one nutrient

01 Chemistry that nutrition actually uses

Every proteinogenic amino acid is an α-amino carboxylic acid. At physiological pH the molecule is a zwitterion: the carboxyl is deprotonated, the α-amino group is protonated, and the side chain decides almost everything else — size, charge, polarity, sulphur, aromaticity, and whether the carbon skeleton can be made in human tissues. Nutrition inherits that chemistry. It does not get to treat “amino acids” as a single substrate any more than organic chemistry treats “side chains” as a single functional group.

Nineteen of the twenty proteinogenic amino acids are chiral at the α-carbon; glycine is not. Human proteins are built from the L-enantiomers. D-amino acids occur in bacterial cell walls and in a few mammalian free pools; they are not a dietary protein-quality problem in ordinary food. What is a dietary problem is the side-chain inventory. Lysine and threonine have no safe transamination escape in humans. The branched-chain amino acids — leucine, isoleucine, valine — share the mitochondrial branched-chain aminotransferase and the branched-chain keto-acid dehydrogenase complex, so they compete with one another for the same first steps (Harper et al., 1984). The aromatic amino acids share transport systems with one another and with large neutral amino acids at the blood–brain barrier, which is why tryptophan availability is not just a protein-intake question (Fernstrom and Wurtman, 1971; Fernstrom, 2013).

Taurine is often sold beside amino-acid supplements and is therefore inside the scope of this article. It is not a proteinogenic amino acid. It is a β-amino sulfonic acid made from cysteine, concentrated in heart, retina, and bile-acid conjugation, and it does not enter peptide bonds. Classifying it with leucine is a retail convenience, not a metabolic one.

FIGURE 1 — SCHEMATICNutritional classes are not chemical classesINDISPENSABLEHis Ile Leu LysMet Phe Thr Trp ValCarbon skeletons cannotbe made at a rate thatmeets need.CONDITIONALArg Gln Cys TyrGly Pro (state-dependent)Synthesis can fall behinddemand in growth, injury,or precursor shortage.DISPENSABLEAla Asp Asn Glu SerMade if nitrogen and acarbon source are present.Not a chemical taxonomy. Membership moves with life stage and disease. Taurine is outside all three boxes.
Figure 1 Nutritional classification of amino acids. The figure is a schematic, not a pathway map and not a dosing chart. Conditional membership is state-dependent.

02 Essential, nonessential, conditionally essential

William Rose’s human depletion experiments in the 1940s and 1950s established the adult indispensable set by removing one amino acid at a time and watching nitrogen balance and clinical signs (Rose, 1957). The modern list for healthy adults is histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. Histidine was the late admission: short nitrogen-balance studies missed a need that longer depletion made visible. That history is the first warning in this article. A method can be internally consistent and still be wrong about a requirement if the observation window is too short.

“Nonessential” is a laboratory word, not a biological one. Alanine, glutamate, and aspartate sit at the centre of nitrogen traffic. The organism can make them; it cannot do without them. The useful distinction is whether the carbon skeleton must be supplied preformed. Even that distinction moves. Arginine is dispensable in healthy adults because the urea cycle can release it, and conditionally indispensable in infants and in some catabolic states because synthesis does not keep up (Wu and Morris, 1998). Cysteine becomes indispensable if methionine is short, because trans-sulphuration is the human route. Tyrosine becomes indispensable if phenylalanine hydroxylase is absent or if phenylalanine intake is too low. Glutamine demand rises in trauma, burns, and critical illness; whether that rise creates a dietary requirement is a clinical question, not a slogan, and it is taken up in Part Five.

Glycine is abundant in collagen and in one-carbon metabolism. Endogenous synthesis is large. Whether it is large enough in ageing or methionine-loaded diets is an open quantitative question, not a settled longevity claim (Meléndez-Hevia and de Paz-Lugo, 2008; McCarty et al., 2018). The article treats that claim as plausible mechanism, unverified human outcome.

03 Nitrogen, pools, and why protein is a rate

The adult body does not store protein the way it stores triglyceride. The free amino-acid pool is small relative to protein-bound amino acids. Whole-body protein turnover in healthy adults is on the order of several hundred grams per day — several times typical dietary protein intake (Waterlow, 2006; Young and Pellett, 1987). The diet therefore tops up a flux, it does not fill a tank. When intake falls, the organism reduces synthesis and, depending on energy and stress hormones, increases breakdown. Nitrogen appears in urea, ammonia, creatinine, and miscellaneous losses. Nitrogen balance is the difference between intake and those measured outputs. It is a necessary idea and a treacherous assay.

The free pools are compartmented. Plasma concentrations are not tissue concentrations. Muscle free glutamine is high; plasma glutamine is not a simple readout of muscle. The splanchnic bed sees portal concentrations that peripheral tissues never see. Branched-chain amino acids escape the liver more than most other amino acids because hepatic branched-chain aminotransferase activity is low; muscle and fat do the first transamination (Harper et al., 1984). That is why a post-prandial rise in plasma BCAA is a real physiological event and why it has been over-interpreted as a signal that BCAA supplements are uniquely anabolic.

Established

Amino acids are chemically and metabolically unlike one another. Indispensability is defined by the inability to make the carbon skeleton at a sufficient rate, not by biological importance. Whole-body protein turnover greatly exceeds typical intake; the free pool is small. These are textbook facts with a long human experimental history (Rose, 1957; Waterlow, 2006).

Part TwoFrom the meal to the tissue

04 Digestion and absorption

Dietary protein is hydrolysed, not absorbed intact in nutritionally relevant amounts. Gastric pepsin opens the structure; pancreatic trypsin, chymotrypsin, elastase, and carboxypeptidases produce oligopeptides; brush-border peptidases finish the job. The enterocyte takes up a mixture of free amino acids and di- and tripeptides. The proton-coupled peptide transporter PEPT1 carries a large fraction of absorbed amino nitrogen as small peptides (Adibi, 1997; Daniel, 2004). That fact matters for scoring: a food’s ileal digestibility is not the same as the appearance of free amino acids in peripheral blood, and a free-amino-acid supplement skips a transport path that meals use.

Absorption is not completion. The enterocyte itself is a major consumer. Glutamate, glutamine, and aspartate are oxidised as fuels of the gut; little of a protein meal’s glutamate reaches the portal vein as glutamate (Reeds et al., 2000; Stoll and Burrin, 2006). Animal work in piglets, which is the best quantitative map of first-pass use, shows extensive extraction of several indispensable amino acids by the portal-drained viscera before the liver is even reached. Human tracer studies are fewer and more constrained, but they agree on the qualitative point: the periphery does not see the meal the plate described (Biolo et al., 1992; Matthews et al., 1993).

05 First-pass splanchnic metabolism

First-pass splanchnic extraction is amino-acid specific. Branched-chain amino acids are extracted less by liver than most other amino acids; phenylalanine, methionine, and the small polar amino acids are extracted more. A human meal therefore delivers a BCAA-enriched signal to muscle relative to the food’s amino-acid profile. That is physiology, not a rationale for removing the other indispensable amino acids from the diet and selling them back as capsules.

The same first-pass step is why free arginine and free glutamine do not behave like arginine or glutamine in food. Oral arginine is taken up and metabolised by gut and liver; oral citrulline bypasses much of that extraction and can raise plasma arginine more efficiently in human pharmacokinetic studies (Schwedhelm et al., 2008). Oral glutamine is a gut fuel first. Plasma increments after a glutamine drink are not proof of a systemic anabolic effect. These are human observations about appearance, not outcome trials.

FIGURE 2 — SCHEMATICA meal is filtered before muscle sees itFood proteinGut oxidationGln Glu AspHepatic useurea, synthesisPeripheryBCAA relatively spared by liver. Free supplements skip some steps and still meet the splanchnic bed.Schematic only. Extraction fractions vary by amino acid, meal, and species. Not a quantitative human balance.
Figure 2 First-pass filtering of meal amino acids. Schematic, not a measured human mass-balance. Piglet and human tracer studies agree on direction, not on a single extraction percentage for every amino acid.

06 Liver, transamination, deamination, the urea cycle, oxidation

Once inside a cell, most amino acids can donate their nitrogen by transamination to α-ketoglutarate, making glutamate, which can then be oxidatively deaminated by glutamate dehydrogenase. The carbon skeletons enter glycolysis, the citrate cycle, or ketone and glucose production. The nitrogen that is not reused becomes urea in periportal hepatocytes through the urea cycle first described by Krebs and Henseleit. Human inborn errors of that cycle are the clinical proof that it is not optional. In ordinary nutrition the cycle is a disposal route: when amino acids are supplied in excess of synthetic need, or when energy is short and protein is used as fuel, urea production rises (Jungas et al., 1992; Morris, 2002).

Oxidation is the irreversible loss. Indicator amino-acid oxidation (IAAO) uses that irreversibility as a measurement: when the test amino acid is below requirement, the indicator (often 13C-phenylalanine) is oxidised; when the test amino acid meets need, the indicator is spared for protein synthesis (Elango et al., 2008; Pencharz and Ball, 2003). The method is now the main competitor to nitrogen balance for indispensable-amino-acid requirements. It is not a muscle-building assay. It estimates the intake at which whole-body oxidative disposal of an indicator stops falling.

07 Sensing: mTORC1, leucine, and the limits of a kinase story

Cells sense amino acids. The most studied pathway is mTORC1. In cultured mammalian cells, leucine is a particularly strong activator; Sestrin2 is a leucine-binding inhibitor of GATOR2, and leucine relieves that inhibition so mTORC1 can move to the lysosome and become active (Wolfson et al., 2016; Saxton et al., 2016; Saxton and Sabatini, 2017). Methionine, arginine, and other amino acids have their own sensors. This is established in vitro and in animals. It is not a human hypertrophy programme.

Human muscle biopsies after protein or leucine drinks show phosphorylation of mTORC1 substrates and a rise in myofibrillar FSR (Atherton et al., 2010; Dickinson et al., 2011). Those measurements last hours. Resistance-training hypertrophy is measured in weeks and months and requires a full complement of indispensable amino acids, mechanical tension, and energy. Acute MPS can rise without a later difference in fibre area or lean mass. Reviews that treat every mTOR blot as a clinical recommendation are doing the work this article exists to refuse.

Ageing complicates the story without simplifying it. Older human muscle often shows a smaller MPS response to a low protein dose and a more intact response when the dose, or its leucine content, is raised (Cuthbertson et al., 2005; Katsanos et al., 2006; Wall et al., 2015). That is anabolic resistance as an acute tracer phenomenon. Whether it is the main cause of sarcopenia, and whether leucine supplements reverse years of loss, are separate questions. The first is strongly supported as a description of acute physiology. The second is not established.

08 Skeletal muscle: synthesis, breakdown, turnover

Muscle protein mass is the difference between MPS and muscle protein breakdown (MPB). Both run continuously. Feeding suppresses MPB and raises MPS; fasting and disuse do the reverse (Biolo et al., 1995; Phillips et al., 1997; Tipton et al., 1999). Tracer methods that report only MPS can miss a change in net balance driven by MPB. Exercise, especially resistance exercise, sensitises muscle to amino acids for a period of hours (Biolo et al., 1997; Tipton and Wolfe, 2001). That is the physiological basis of the “anabolic window.” The window in trained humans is wide, not a thirty-minute door (Schoenfeld and Aragon, 2018).

The most important methodological warning in this part is simple. A four-hour infusion after a drink is not a twelve-week training study. Mitchell and colleagues, and later reviews, have shown that acute MPS differences do not reliably rank hypertrophy outcomes (Mitchell et al., 2014; Damas et al., 2015). This article will keep repeating that sentence until the last controversy is closed.

Strongly supported

Splanchnic first-pass use is large and amino-acid specific. mTORC1 is an amino-acid sensor, and leucine is a potent ligand in cells. Human muscle MPS rises after protein feeding and after resistance exercise. Acute MPS is a weak predictor of long-term hypertrophy. Each clause has a different evidence type; they are not one clause.

Part ThreeHow much, of what, and from which foods

09 Nitrogen balance and its over-trust

Nitrogen balance looks like bookkeeping. Intake minus output should equal zero in a healthy adult who is neither growing nor wasting. The method built the twentieth-century protein and amino-acid requirement tables (Rose, 1957; Rand et al., 2003). It is still cited as if it were a gold standard. It is not.

Unmeasured losses — sweat, hair, skin, miscellaneous nitrogen — are estimated, not fully collected. Adaptation to a low intake can restore balance at a new, lower lean-mass set point. Short studies miss slow depletion, as they did for histidine. Positive balance in a growing child is required; zero balance in an older adult who is already sarcopenic is not a success. Young and colleagues, and later Millward, argued for years about whether nitrogen-balance estimates were too low (Young and Marchini, 1990; Millward, 1998). The argument was not pedantry. It decided official numbers that still sit in policy documents.

IAAO and 24-hour indicator-oxidation protocols were developed in part because of those defects (Pencharz and Ball, 2003; Elango et al., 2008, 2012). They tend to give higher indispensable-amino-acid estimates than classical nitrogen balance. They are still whole-body methods. They do not tell a clinician how much protein an 80-year-old needs to recover gait speed, and they do not tell a coach how much leucine to put in a shaker.

10 Indispensable amino-acid requirements

The WHO/FAO/UNU 2007 report remains the international reference for adult indispensable amino acids, expressed in milligrams per kilogram per day and as a pattern for scoring (WHO/FAO/UNU, 2007). The US/Canadian DRI for protein, 0.80 g·kg−1·d−1 for healthy adults, is an estimated average requirement plus a safety factor for protein as a whole, not a hypertrophy target (Institute of Medicine, 2005). EFSA later published its own dietary reference values (EFSA NDA Panel, 2012). These documents are established as policy references. They are not interchangeable with sports-nutrition position stands or geriatric consensus statements, which use different endpoints.

IAAO re-estimates for lysine, sulphur amino acids, and other indispensable amino acids have often exceeded the 2007 WHO numbers (Elango et al., 2012; Pillai and Kurpad, 2012). Pregnancy IAAO work suggests higher lysine and protein needs than non-pregnant adult values (Elango and Ball, 2016). Those studies are human, small, and method-specific. This article reports them as strongly supported method-dependent estimates, not as intake advice.

ReferenceEndpointWhat it estimatesWhat it is not
Rose depletion studiesN balance, clinical signsAdult indispensable setA modern quantitative table
WHO/FAO/UNU 2007Mostly N balance, some kineticsInternational adult IAA patternAthlete or sarcopenia guidance
IOM DRI 2005N balance meta-analysisProtein EAR/RDAA leucine threshold
IAAO (Pencharz/Elango)Indicator oxidation breakpointIAA intake at oxidative sparingHypertrophy or longevity
PROT-AGE / ESPENFunction, lean mass, illnessOlder-adult and clinical protein ranges studiedIsolated amino-acid doses
Table. Requirement systems answer different questions. Numbers from one column must not be copied into another.

11 Scoring: PDCAAS, DIAAS, digestibility, limiting amino acids

A food can supply enough protein nitrogen and still be limited by one indispensable amino acid. The limiting amino acid is the one whose digestible supply, relative to the reference pattern, is lowest. In many cereals it is lysine; in many legumes it is methionine plus cysteine; in some diets it is lysine and the sulphur amino acids together. Complementary proteins are meals or daily patterns that cover each other’s gaps. That is a food-pattern idea. It is not a requirement to combine rice and beans in the same bite.

PDCAAS scores a food by faecal crude-protein digestibility times the limiting amino-acid score, and truncates values above 1.0 (Schaafsma, 2000; FAO/WHO, 1991). DIAAS uses ileal digestibility of individual indispensable amino acids and does not truncate, so high-quality animal proteins can score above 100% (FAO, 2013; Rutherfurd et al., 2015). Ileal digestibility is the better physiological number because colon microbes alter faecal amino-acid disappearance. Human ileal data are still thinner than pig data. Wolfe and colleagues have argued that DIAAS better reflects the value of high-quality proteins for humans (Wolfe et al., 2016). Plant proteins generally score lower, not because plants are “incomplete” in a mystical sense, but because digestibility and the limiting amino acid are often less favourable.

These scores compare foods. They do not compare leucine capsules to beef. A supplement that supplies one amino acid can raise a score on paper and still leave the other eight indispensable amino acids untouched.

12 Plant versus animal protein

Human acute MPS studies have repeatedly shown smaller myofibrillar FSR responses to some plant proteins than to matched-protein milk or whey, especially at moderate doses, with the gap narrowing when the plant dose is increased or the amino-acid profile is fortified (Tang et al., 2009; van Vliet et al., 2015; Gorissen et al., 2016; Pinckaers et al., 2021). That is strongly supported as an acute tracer finding. Long-term hypertrophy trials in vegans versus omnivores, when total protein and training are matched, are fewer. Hevia-Larraín and colleagues reported that a high-protein vegan diet could support similar lean-mass gains to an omnivorous diet in young men during resistance training (Hevia-Larraín et al., 2021). Adequacy is therefore a function of total protein, amino-acid pattern, digestibility, and energy — not a moral property of the food kingdom.

The popular claim that plant protein is inherently inadequate is false at the level of a well-planned diet. The popular claim that plant and animal proteins are interchangeable at the same gram weight for the same acute MPS response is also false at typical serving sizes. Both overstatements fail the same test: they drop the limiting amino acid and the digestibility correction.

13 Meal distribution and the leucine-threshold concept

Moore and colleagues described a saturable dose–response of myofibrillar FSR to ingested protein after resistance exercise in young men (Moore et al., 2009). Witard and others refined the curve (Witard et al., 2014). Older adults often need a larger protein dose, or more leucine in the dose, to reach a similar acute FSR (Katsanos et al., 2006; Moore et al., 2015). From these data came the “leucine threshold”: a per-meal leucine amount below which MPS is not fully switched on.

The concept is useful as a description of acute human tracer studies. It becomes a dogma when it is treated as a daily law. Mamerow and colleagues found, in a 7-day crossover in healthy adults, that even protein distribution produced higher 24-hour MPS than a skewed pattern at the same total protein (Mamerow et al., 2014). Areta and colleagues showed that 20 g of protein every three hours after exercise outperformed smaller pulses or two large boluses for myofibrillar FSR over 12 hours (Areta et al., 2013). Those are short studies. They do not prove that anyone who misses a leucine target at breakfast will lose muscle. They do argue against the idea that a single large protein meal can be assumed to do the whole day’s work.

The anabolic window after training is real as a period of heightened amino-acid sensitivity and overstated as a stopwatch (Schoenfeld and Aragon, 2018). Total daily protein, energy balance, and the training stimulus still dominate long-term trials (Morton et al., 2018).

Do not conflate

A DIAAS score, an IAAO breakpoint, a per-meal leucine threshold, and a sports-nutrition protein range are four different objects. Dietary protein evidence is not isolated-amino-acid evidence. Acute FSR is not hypertrophy.

Part FourThe same gram, different bodies

14 Exercise and recovery

Resistance exercise raises MPS and, for a time, MPB; feeding tilts the balance toward net gain (Biolo et al., 1997; Phillips et al., 1997). Endurance exercise oxidises amino acids, especially BCAA, as a minor but real fuel when glycogen is low (Rennie et al., 2006). Recovery protein in athletes is therefore a question about net muscle protein balance and about glycogen and energy, not about a unique amino-acid potion.

Morton and colleagues’ meta-analysis of protein supplementation during resistance training found a positive effect on fat-free mass and strength, with diminishing returns as total daily protein rose, and little additional benefit once intake was already high (Morton et al., 2018). The typical effective contrast was protein versus carbohydrate or lower protein, not leucine versus an isonitrogenous mixed protein. ISSN and related position stands summarise that literature as support for higher-than-RDA protein in athletes (Jäger et al., 2017). Those stands are secondary documents. They are not amino-acid-supplement trials.

When supplement studies fail to match total protein and energy, they cannot be read as evidence for a specific amino acid. That design flaw is common in BCAA and leucine papers and is one of the adversarial review attacks this article accepts as decisive.

15 Aging, anabolic resistance, sarcopenia

Sarcopenia is a clinical syndrome of low muscle mass, strength, and function (Cruz-Jentoft et al., 2010, 2019). Anabolic resistance is a physiological description: a smaller MPS response to a given protein or amino-acid dose in older than in younger adults (Cuthbertson et al., 2005; Wall et al., 2015). The two are related and not identical. A person can show anabolic resistance in a tracer study without meeting sarcopenia criteria. A person can be sarcopenic because of disuse, disease, and energy deficit even if a large protein dose still raises FSR.

PROT-AGE and ESPEN expert groups reviewed human data and recommended higher protein intakes for older adults than the adult RDA, especially in illness, with attention to per-meal protein and leucine-rich foods (Bauer et al., 2013; Deutz et al., 2014). Those documents are consensus, not randomised proof that a specific leucine supplement prevents disability. Human trials of leucine or essential-amino-acid mixtures in older adults show mixed effects on acute MPS and inconsistent effects on long-term lean mass and function when background diet is already adequate (Dillon et al., 2009; Verhoeven et al., 2009; Leenders et al., 2011). The honest summary is emerging for food-protein pattern in older adults; not established for isolated leucine as a sarcopenia drug.

Athlete data must not be generalised to older adults, and geriatric consensus must not be generalised to young athletes. The same 25-gram protein serving is a different physiological event in those two bodies.

16 Pregnancy, childhood, growth

Growth is positive nitrogen balance by definition. Fetal and infant indispensable-amino-acid needs include arginine and histidine in a way adult maintenance does not. Human milk and complementary foods are the ordinary vehicles. IAAO in pregnant women suggests higher lysine and protein requirements than non-pregnant adult values (Elango and Ball, 2016; Payne et al., 2018). Those studies are small human protocols. They are not prenatal supplement recipes.

Childhood protein-quality crises are still lysine and digestibility crises in cereal-based diets. That is a public-health fact with a long field history (Kurpad and Thomas, 2011). It is not evidence that healthy children in protein-sufficient households need amino-acid bottles.

17 Fasting and caloric restriction

In a fast, hepatic gluconeogenesis consumes amino-acid carbon, urea production rises, and muscle net balance goes negative (Cahill, 2006; Owen et al., 1998). The organism defends glucose and essential functions, not gym measurements. Protein-sparing during caloric restriction is improved when protein intake is kept high relative to energy and when resistance training is present (Pasiakos et al., 2013; Longland et al., 2016; Hector and Phillips, 2018). Those are human body-composition trials of dietary protein and training, not of isolated amino acids.

Caloric restriction and protein restriction are different interventions. Rodent life-extension has been reported with methionine restriction and with low-protein, high-carbohydrate diets (Orentreich et al., 1993; Miller et al., 2005; Solon-Biet et al., 2014). Human observational work linking high animal protein to IGF-1 and mortality in middle age is not a methionine-restriction trial (Levine et al., 2014). The leap from those papers to a human longevity protocol is the leap Part Five refuses.

18 Disease and catabolic states

Trauma, burns, sepsis, and cancer cachexia raise whole-body protein breakdown and change amino-acid demand (Wolfe, 2005; Biolo et al., 1997). Glutamine consumption by immune cells and gut mucosa rises. Whether extra glutamine helps is a trial question. In the REDOXS trial, Heyland and colleagues randomised critically ill adults with multiorgan failure to glutamine, antioxidants, both, or placebo; early glutamine was associated with increased mortality (Heyland et al., 2013). SIGNET did not show benefit of parenteral glutamine in a large ICU population (Andrews et al., 2011). Those human outcomes sit above a mountain of mechanistic plausibility. They are why this article will not treat glutamine as a general tonic.

Arginine is a precursor of nitric oxide and of urea-cycle intermediates. Immunonutrition cocktails that include arginine have mixed surgical and ICU results and are not reviewed here as a licence to dose arginine. Citrulline’s cleaner oral pharmacokinetics do not by themselves make it a clinical therapy (Schwedhelm et al., 2008; Cynober et al., 2013).

Population error

An athlete study is not an older-adult study. An ICU trial is not a healthy-user study. A rodent longevity cage is not a human life. The amino acid may be the same; the claim is not.

Part FiveIsolated amino acids and the claims made for them

19 Leucine and the branched-chain amino acids

Leucine is an indispensable amino acid, a preferred mTORC1 ligand in cells, and a strong acute stimulus of human MPS when the other indispensable amino acids are available (Atherton et al., 2010; Churchward-Venne et al., 2012). Isolated BCAA supplements supply leucine, isoleucine, and valine and omit lysine, methionine, threonine, histidine, phenylalanine, and tryptophan. Wolfe’s review of that biochemistry is blunt: BCAA alone cannot make new muscle protein because the other indispensable amino acids are missing (Wolfe, 2017). Human trials that add BCAA on top of an already protein-sufficient diet often measure soreness, fatigue, or a few hours of FSR. They rarely measure hypertrophy against an isonitrogenous control. Meta-analyses of BCAA and exercise performance are mixed and frequently include studies that did not control total protein (Plotkin et al., 2021; Khemtong et al., 2021).

Leucine co-ingestion can raise the acute MPS response to a suboptimal protein dose in young and older adults (Churchward-Venne et al., 2014; Wall et al., 2013). That is a real human tracer finding. Long-term leucine supplementation in older men has failed to increase muscle mass or strength in randomised trials when the background diet was adequate (Verhoeven et al., 2009; Leenders et al., 2011). The red-team challenge holds: acute MPS was confused with hypertrophy; supplement studies were inadequately controlled for total protein; athletes were generalised to older adults and the reverse.

Circulating BCAA are also elevated in obesity and type 2 diabetes (Newgard et al., 2009; White and Newgard, 2019). Whether they are causal or a marker of impaired disposal is not settled in humans. They are not a reason to prescribe BCAA, and they are not, by themselves, a reason to forbid dietary protein.

20 Lysine, methionine, cysteine

Lysine is the limiting indispensable amino acid in many cereal diets. Human IAAO estimates of lysine requirement have been higher than some older nitrogen-balance values (Kurpad et al., 2003; Elango et al., 2012). Lysine fortification of cereals is a public-health intervention with a different evidence base from lysine capsules sold to protein-sufficient adults.

Methionine is indispensable, a methyl donor, and the precursor of cysteine via trans-sulphuration. Methionine restriction extends lifespan in rats and mice and improves some metabolic markers in rodents (Orentreich et al., 1993; Richie et al., 1994; Miller et al., 2005). Those are established animal findings. Human evidence is limited to short dietary studies and observational protein-pattern work. There is no randomised human demonstration that methionine restriction extends life or reduces hard clinical events. The red-team challenge on rodent-to-human longevity extrapolation is accepted. Cysteine and glutathione status can fall if sulphur amino acids are too low; the direction of risk is not only “less methionine is better.”

21 Glycine and the longevity claim

Glycine is used in collagen, glutathione, creatine, and one-carbon metabolism. Endogenous synthesis is large. McCarty and others have argued that glycine may be conditionally short when methionine is high, and that glycine supplementation might mimic some features of methionine restriction (McCarty et al., 2018). Rodent glycine supplementation has been reported to extend life in some studies (Miller et al., 2019). Human trials with longevity or validated ageing endpoints do not exist. Sleep and metabolic-marker studies are not life-extension trials. Grade: plausible mechanism, speculative human longevity claim.

22 Glutamine: healthy versus clinical

Glutamine is the most abundant free amino acid in human muscle and plasma. It fuels enterocytes and immune cells (Newsholme, 2001; Cruzat et al., 2018). In healthy athletes, glutamine supplements have not consistently reduced illness or improved performance when diet is adequate (Gleeson, 2008). In critical illness, the mechanistic story predicted benefit. REDOXS found harm with early high-dose glutamine in patients with multiorgan failure (Heyland et al., 2013). SIGNET did not find benefit (Andrews et al., 2011). ASPEN and ESPEN later narrowed or withdrew routine high-dose glutamine recommendations. The lesson is not that glutamine is unimportant. The lesson is that a plausible pathway plus a small early trial is not a licence to generalise from healthy gym users to ICU patients or the reverse.

23 Arginine versus citrulline

Arginine is a urea-cycle intermediate and the substrate of nitric oxide synthases. Oral arginine undergoes substantial first-pass metabolism. Oral citrulline raises plasma arginine more efficiently in human pharmacokinetic studies and can raise NO-related markers (Schwedhelm et al., 2008; Bahri et al., 2013). Exercise and blood-pressure trials of citrulline are mixed and often small (Figueroa et al., 2017). Neither amino acid has the outcome evidence of an antihypertensive drug or a training programme. The correct comparison is pharmacokinetic and mechanistic, not “citrulline is the better arginine.”

24 Tryptophan, histidine, taurine

Tryptophan is indispensable, the precursor of serotonin and of niacin, and a competitor with other large neutral amino acids for brain uptake (Fernstrom, 2013). Human requirement estimates exist; mood and sleep claims for isolated tryptophan or 5-hydroxytryptophan are a different literature and are not settled here as nutrition science. Histidine is indispensable; short studies missed it; haemoglobin and carnosine bind large amounts. Taurine is not proteinogenic. Human taurine trials in heart failure, metabolic disease, and performance exist and are heterogeneous (Waldron et al., 2018; Schaffer and Kim, 2018). They do not make taurine an honorary essential amino acid for healthy adults eating mixed diets.

25 What the controversies actually turn on

FIGURE 3 — EVIDENCE LADDERA kinase is not a year of human outcome1 In vitro sensing (mTORC1, Sestrin2) — established in cells2 Animal longevity or hypertrophy — species named, not human3 Acute human MPS / signalling — hours, not months4 Human RCT of function, mass, or clinical events5 Hard human endpoints over years — usually absentEach lower rung can be true while the rungs above it remain empty. That emptiness is a finding.
Figure 3 Mechanistic-to-clinical ladder used throughout this article. Measured human rungs are labelled as such. Projected leaps are labelled as leaps.

The controversies named in the commission reduce to a short list of errors.

BCAA and leucine supplementation. Acute MPS and cell signalling are real. Durable hypertrophy against protein-matched controls in protein-sufficient humans is not established. Wolfe’s missing-IAA argument remains the chemical veto on BCAA-only muscle building.

Methionine restriction and glycine for longevity. Rodent findings are strong enough to be interesting. Human outcome evidence is not. Observational protein-pattern papers are not methionine-restriction trials.

Glutamine. Healthy-user studies are mostly null. Large ICU trials were not a success and one was a harm signal. The populations are not interchangeable.

Arginine versus citrulline. Pharmacokinetics favour citrulline for raising plasma arginine. Outcome superiority is not established.

Amino-acid supplements for muscle gain. Protein-plus-training evidence is stronger than isolated-amino-acid evidence. Design sins include unmatched protein, short endpoints, and athlete-to-elder generalisation.

Plant-protein adequacy. Adequacy is achievable with attention to total protein, digestibility, and limiting amino acids. Acute MPS equivalence at equal grams is not guaranteed.

Anabolic window and per-meal thresholds. Both describe real acute physiology. Both become false when treated as stopwatches or as substitutes for daily protein and training.

Amino-acid sensing and ageing. Anabolic resistance is a documented acute phenomenon. It does not by itself prove that an mTOR-targeted amino-acid supplement is a sarcopenia therapy.

Standing constraint

This document describes published research. It is not medical advice. No human use, dose, route or schedule is recommended anywhere in this document. Nothing here is a prescription, a sports protocol, or a longevity regimen.

ApparatusReferences, evidence handling, limitations

26 References

The numbered list is generated from verified NCBI or primary-agency records. Identifiers that could not be resolved were not printed. Author–year citations in the text correspond to this list.

  1. Ables Gene P, Brown-Borg Holly M, Buffenstein Rochelle, Church Christopher D, Elshorbagy Amany K, Gladyshev Vadim N, et al.. The first international mini-symposium on methionine restriction and lifespan. Front Genet. 2014;5:122.
    PMID 24847356 · PMC4023024 · doi:10.3389/fgene.2014.00122
  2. Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, et al.. Arginase Deficiency. . 1993.
    PMID 20301338
  3. Adebayo Daniel, Obaseki Eseiwi, Vasudeva Kashvi, Aboumourad Marwa, Miller Scott, Ostermeyer-Fay Anne, et al.. Sphingolipid regulation by yeast Mdm1 supports adaptive remodeling of the methionine transporter Mup1. Mol Biol Cell. 2026;37(7):ar65.
    PMID 42202073 · PMC13329864 · doi:10.1091/mbc.E26-03-0111
  4. Andrews Peter J D, Avenell Alison, Noble David W, Campbell Marion K, Battison Claire G, Croal Bernard L, et al.. Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial). Trials. 2007;8:25.
    PMID 17883854 · PMC2082027 · doi:10.1186/1745-6215-8-25
  5. Andrews Peter J D. Selenium and glutamine supplements: where are we heading? A critical care perspective. Curr Opin Clin Nutr Metab Care. 2010;13(2):192-7.
    PMID 20040860 · doi:10.1097/MCO.0b013e32833617cd
  6. Aragon Alan Albert, Schoenfeld Brad Jon. Nutrient timing revisited: is there a post-exercise anabolic window?. J Int Soc Sports Nutr. 2013;10(1):5.
    PMID 23360586 · PMC3577439 · doi:10.1186/1550-2783-10-5
  7. Areta José L, Burke Louise M, Ross Megan L, Camera Donny M, West Daniel W D, Broad Elizabeth M, et al.. Timing and distribution of protein ingestion during prolonged recovery from resistance exercise alters myofibrillar protein synthesis. J Physiol. 2013;591(9):2319-31.
    PMID 23459753 · PMC3650697 · doi:10.1113/jphysiol.2012.244897
  8. Areta José L, Burke Louise M, Camera Donny M, West Daniel W D, Crawshay Siobhan, Moore Daniel R, et al.. Reduced resting skeletal muscle protein synthesis is rescued by resistance exercise and protein ingestion following short-term energy deficit. Am J Physiol Endocrinol Metab. 2014;306(8):E989-97.
    PMID 24595305 · doi:10.1152/ajpendo.00590.2013
  9. Askow Andrew T, Barnes Takeshi M, Zupancic Zan, Deutz Max T, Paulussen Kevin J M, McKenna Colleen F, et al.. Impact of Vegan Diets on Resistance Exercise-Mediated Myofibrillar Protein Synthesis in Healthy Young Males and Females: A Randomized Controlled Trial. Med Sci Sports Exerc. 2025;57(9):1923-1934.
    PMID 40197715 · doi:10.1249/MSS.0000000000003725
  10. Atherton Philip J, Kumar Vinod, Selby Anna L, Rankin Debbie, Hildebrandt Wulf, Phillips Beth E, et al.. Enriching a protein drink with leucine augments muscle protein synthesis after resistance exercise in young and older men. Clin Nutr. 2017;36(3):888-895.
    PMID 27208923 · doi:10.1016/j.clnu.2016.04.025
  11. Bauer Jürgen, Biolo Gianni, Cederholm Tommy, Cesari Matteo, Cruz-Jentoft Alfonso J, Morley John E, et al.. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-59.
    PMID 23867520 · doi:10.1016/j.jamda.2013.05.021
  12. Bauer Juergen M, Diekmann Rebecca. Protein supplementation with aging. Curr Opin Clin Nutr Metab Care. 2015;18(1):24-31.
    PMID 25474010 · doi:10.1097/MCO.0000000000000124
  13. Beaufrère B, Dangin M, Boirie Y. The 'fast' and 'slow' protein concept. Nestle Nutr Workshop Ser Clin Perform Programme. 2000;3:121-31; discussion 131-3.
    PMID 11490603
  14. Beier Marcel P, Kojima Soichi. The function of high-affinity urea transporters in nitrogen-deficient conditions. Physiol Plant. 2021;171(4):802-808.
    PMID 33280129 · doi:10.1111/ppl.13303
  15. Biolo G, Wolfe R R. Insulin action on protein metabolism. Baillieres Clin Endocrinol Metab. 1993;7(4):989-1005.
    PMID 8304920 · doi:10.1016/s0950-351x(05)80242-3
  16. Boirie Y, Dangin M, Gachon P, Vasson M P, Maubois J L, Beaufrère B. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci U S A. 1997;94(26):14930-5.
    PMID 9405716 · PMC25140 · doi:10.1073/pnas.94.26.14930
  17. Boirie Yves, Guillet Christelle. Fast digestive proteins and sarcopenia of aging. Curr Opin Clin Nutr Metab Care. 2018;21(1):37-41.
    PMID 29028650 · doi:10.1097/MCO.0000000000000427
  18. Breen Leigh, Phillips Stuart M. Skeletal muscle protein metabolism in the elderly: Interventions to counteract the 'anabolic resistance' of ageing. Nutr Metab (Lond). 2011;8:68.
    PMID 21975196 · PMC3201893 · doi:10.1186/1743-7075-8-68
  19. Brosnan John T, Brosnan Margaret E. The sulfur-containing amino acids: an overview. J Nutr. 2006;136(6 Suppl):1636S-1640S.
    PMID 16702333 · doi:10.1093/jn/136.6.1636S
  20. Brosnan Margaret E, Brosnan John T. Histidine Metabolism and Function. J Nutr. 2020;150(Suppl 1):2570S-2575S.
    PMID 33000155 · PMC7527268 · doi:10.1093/jn/nxaa079
  21. Burk Raymond F, Hill Kristina E. Regulation of Selenium Metabolism and Transport. Annu Rev Nutr. 2015;35:109-34.
    PMID 25974694 · doi:10.1146/annurev-nutr-071714-034250
  22. Burstad Kendal M, Lamina Toyin, Erickson Amy, Gholizadeh Esmaeel, Namigga Hildah, Claussen Amy M, et al.. Evaluation of dietary protein and amino acid requirements: a systematic review. Am J Clin Nutr. 2025;122(1):285-305.
    PMID 40610129 · doi:10.1016/j.ajcnut.2025.04.017
  23. Chandel Navdeep S. Amino Acid Metabolism. Cold Spring Harb Perspect Biol. 2021;13(4).
    PMID 33795250 · PMC8015690 · doi:10.1101/cshperspect.a040584
  24. Chu Helen Y, Englund Janet A. Maternal immunization. Birth Defects Res. 2017;109(5):379-386.
    PMID 28398678 · doi:10.1002/bdra.23547
  25. Churchward-Venne Tyler A, Breen Leigh, Phillips Stuart M. Alterations in human muscle protein metabolism with aging: Protein and exercise as countermeasures to offset sarcopenia. Biofactors. 2014;40(2):199-205.
    PMID 24105883 · doi:10.1002/biof.1138
  26. Courtney-Martin Glenda, Ball Ronald O, Pencharz Paul B, Elango Rajavel. Protein Requirements during Aging. Nutrients. 2016;8(8).
    PMID 27529275 · PMC4997405 · doi:10.3390/nu8080492
  27. Cruz-Jentoft Alfonso J, Baeyens Jean Pierre, Bauer Jürgen M, Boirie Yves, Cederholm Tommy, Landi Francesco, et al.. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-23.
    PMID 20392703 · PMC2886201 · doi:10.1093/ageing/afq034
  28. Cruz-Jentoft Alfonso J, Bahat Gülistan, Bauer Jürgen, Boirie Yves, Bruyère Olivier, Cederholm Tommy, et al.. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31.
    PMID 30312372 · PMC6322506 · doi:10.1093/ageing/afy169
  29. Cruz-Jentoft Alfonso J, Bahat Gϋlistan, Bauer Jϋrgen, Boirie Yves, Bruyère Olivier, Cederholm Tommy, et al.. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601.
    PMID 31081853 · PMC6593317 · doi:10.1093/ageing/afz046
  30. Curis Emmanuel, Crenn Pascal, Cynober Luc. Citrulline and the gut. Curr Opin Clin Nutr Metab Care. 2007;10(5):620-6.
    PMID 17693747 · doi:10.1097/MCO.0b013e32829fb38d
  31. Cuthbertson Daniel, Smith Kenneth, Babraj John, Leese Graham, Waddell Tom, Atherton Philip, et al.. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005;19(3):422-4.
    PMID 15596483 · doi:10.1096/fj.04-2640fje
  32. d'Unienville Noah M A, Blake Henry T, Coates Alison M, Hill Alison M, Nelson Maximillian J, Buckley Jonathan D. Effect of food sources of nitrate, polyphenols, L-arginine and L-citrulline on endurance exercise performance: a systematic review and meta-analysis of randomised controlled trials. J Int Soc Sports Nutr. 2021;18(1):76.
    PMID 34965876 · PMC8715640 · doi:10.1186/s12970-021-00472-y
  33. Deutz Nicolaas E P, Bauer Jürgen M, Barazzoni Rocco, Biolo Gianni, Boirie Yves, Bosy-Westphal Anja, et al.. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014;33(6):929-36.
    PMID 24814383 · PMC4208946 · doi:10.1016/j.clnu.2014.04.007
  34. Duncan A M, Ball R O, Pencharz P B. Lysine requirement of adult males is not affected by decreasing dietary protein. Am J Clin Nutr. 1996;64(5):718-25.
    PMID 8901791 · doi:10.1093/ajcn/64.5.718
  35. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on Dietary Reference Values for chromium. EFSA J. 2014;12(10):3845.
    PMID 42087961 · PMC13136993 · doi:10.2903/j.efsa.2014.3845
  36. Elango Rajavel, Humayun Mohammad A, Ball Ronald O, Pencharz Paul B. Lysine requirement of healthy school-age children determined by the indicator amino acid oxidation method. Am J Clin Nutr. 2007;86(2):360-5.
    PMID 17684206 · doi:10.1093/ajcn/86.2.360
  37. Elango Rajavel, Ball Ronald O, Pencharz Paul B. Indicator amino acid oxidation: concept and application. J Nutr. 2008;138(2):243-6.
    PMID 18203885 · doi:10.1093/jn/138.2.243
  38. Elango Rajavel, Ball Ronald O, Pencharz Paul B. Recent advances in determining protein and amino acid requirements in humans. Br J Nutr. 2012;108 Suppl 2:S22-30.
    PMID 23107531 · doi:10.1017/S0007114512002504
  39. Elango Rajavel, Ball Ronald O. Protein and Amino Acid Requirements during Pregnancy. Adv Nutr. 2016;7(4):839S-44S.
    PMID 27422521 · PMC4942872 · doi:10.3945/an.115.011817
  40. Ennis Madeleine A, Ong Anna-Joy, Lim Kenneth, Ball Ronald O, Pencharz Paul B, Courtney-Martin Glenda, et al.. Dietary Aromatic Amino Acid Requirements During Early and Late Gestation in Healthy Pregnant Women. J Nutr. 2020;150(12):3224-3230.
    PMID 33188409 · PMC7726121 · doi:10.1093/jn/nxaa317
  41. Fern E B, Waterlow J C. Protein turnover, nitrogen balance and rehabilitation. Experientia Suppl. 1983;44:89-106.
    PMID 6357851 · doi:10.1007/978-3-0348-6540-1_7
  42. Ferrando Arny A, Wolfe Robert R, Hirsch Katie R, Church David D, Kviatkovsky Shiloah A, Roberts Michael D, et al.. International Society of Sports Nutrition Position Stand: Effects of essential amino acid supplementation on exercise and performance. J Int Soc Sports Nutr. 2023;20(1):2263409.
    PMID 37800468 · PMC10561576 · doi:10.1080/15502783.2023.2263409
  43. Forsby Mathilda, Hulander Erik, Amberntsson Anna, Brembeck Petra, Winkvist Anna, Bärebring Linnea, et al.. Nutritional intake and determinants of nutritional quality changes from pregnancy to postpartum-a longitudinal study. Food Sci Nutr. 2024;12(2):1245-1256.
    PMID 38370042 · PMC10867539 · doi:10.1002/fsn3.3838
  44. Franzago Marica, Alessandrelli Elisa, Notarangelo Stefania, Stuppia Liborio, Vitacolonna Ester. Chrono-Nutrition: Circadian Rhythm and Personalized Nutrition. Int J Mol Sci. 2023;24(3).
    PMID 36768893 · PMC9916946 · doi:10.3390/ijms24032571
  45. Gielen Evelien, Beckwée David, Delaere Andreas, De Breucker Sandra, Vandewoude Maurits, Bautmans Ivan, et al.. Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Nutr Rev. 2021;79(2):121-147.
    PMID 32483625 · doi:10.1093/nutrit/nuaa011
  46. Gorissen Stefan H M, Crombag Julie J R, Senden Joan M G, Waterval W A Huub, Bierau Jörgen, Verdijk Lex B, et al.. Protein content and amino acid composition of commercially available plant-based protein isolates. Amino Acids. 2018;50(12):1685-1695.
    PMID 30167963 · PMC6245118 · doi:10.1007/s00726-018-2640-5
  47. Green Cara L, Lamming Dudley W, Fontana Luigi. Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol. 2022;23(1):56-73.
    PMID 34518687 · PMC8692439 · doi:10.1038/s41580-021-00411-4
  48. Guillon F, Champ M M-J. Carbohydrate fractions of legumes: uses in human nutrition and potential for health. Br J Nutr. 2002;88 Suppl 3:S293-306.
    PMID 12498630 · doi:10.1079/BJN2002720
  49. Hector Amy J, Phillips Stuart M. Protein Recommendations for Weight Loss in Elite Athletes: A Focus on Body Composition and Performance. Int J Sport Nutr Exerc Metab. 2018;28(2):170-177.
    PMID 29182451 · doi:10.1123/ijsnem.2017-0273
  50. Henriksen Christine, Bügel Susanne. Chromium - a scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res. 2023;67.
    PMID 38084146 · PMC10710855 · doi:10.29219/fnr.v67.10325
  51. Heyland Daren K, Dhaliwal Rupinder, Day Andrew G, Muscedere John, Drover John, Suchner Ulrich, et al.. REducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc. 2006;65(3):250-63.
    PMID 16923310 · doi:10.1079/pns2006505
  52. Heyland Daren K, Dhaliwal Rupinder. Role of glutamine supplementation in critical illness given the results of the REDOXS study. JPEN J Parenter Enteral Nutr. 2013;37(4):442-3.
    PMID 23639898 · doi:10.1177/0148607113488421
  53. Heyland Daren K, Wibbenmeyer Lucy, Pollack Jonathan, Friedman Bruce, Turgeon Alexis F, Eshraghi Niknam, et al.. A Randomized Trial of Enteral Glutamine for Treatment of Burn Injuries. N Engl J Med. 2022;387(11):1001-1010.
    PMID 36082909 · doi:10.1056/NEJMoa2203364
  54. Hodgkinson Suzanne M, Montoya Carlos A, Scholten Patty T, Rutherfurd Shane M, Moughan Paul J. Cooking Conditions Affect the True Ileal Digestible Amino Acid Content and Digestible Indispensable Amino Acid Score (DIAAS) of Bovine Meat as Determined in Pigs. J Nutr. 2018;148(10):1564-1569.
    PMID 30204886 · doi:10.1093/jn/nxy153
  55. Hoffer L John. Human Protein and Amino Acid Requirements. JPEN J Parenter Enteral Nutr. 2016;40(4):460-74.
    PMID 26796095 · doi:10.1177/0148607115624084
  56. Hughes Glenna J, Ryan David J, Mukherjea Ratna, Schasteen Charles S. Protein digestibility-corrected amino acid scores (PDCAAS) for soy protein isolates and concentrate: criteria for evaluation. J Agric Food Chem. 2011;59(23):12707-12.
    PMID 22017752 · doi:10.1021/jf203220v
  57. Häberle Johannes, Burlina Alberto, Chakrapani Anupam, Dixon Marjorie, Karall Daniela, Lindner Martin, et al.. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis. 2019;42(6):1192-1230.
    PMID 30982989 · doi:10.1002/jimd.12100
  58. Højfeldt Grith, Bülow Jacob, Agergaard Jakob, Asmar Ali, Schjerling Peter, Simonsen Lene, et al.. Impact of habituated dietary protein intake on fasting and postprandial whole-body protein turnover and splanchnic amino acid metabolism in elderly men: a randomized, controlled, crossover trial. Am J Clin Nutr. 2020;112(6):1468-1484.
    PMID 32710741 · doi:10.1093/ajcn/nqaa201
  59. Jackman Sarah R, Witard Oliver C, Philp Andrew, Wallis Gareth A, Baar Keith, Tipton Kevin D. Branched-Chain Amino Acid Ingestion Stimulates Muscle Myofibrillar Protein Synthesis following Resistance Exercise in Humans. Front Physiol. 2017;8:390.
    PMID 28638350 · PMC5461297 · doi:10.3389/fphys.2017.00390
  60. Johnson Adiv A, Cuellar Trinna L. Glycine and aging: Evidence and mechanisms. Ageing Res Rev. 2023;87:101922.
    PMID 37004845 · doi:10.1016/j.arr.2023.101922
  61. Joint WHO/FAO/UNU Expert Consultation. Protein and amino acid requirements in human nutrition. World Health Organ Tech Rep Ser. 2007:1-265, back cover.
    PMID 18330140
  62. Jäger Ralf, Kerksick Chad M, Campbell Bill I, Cribb Paul J, Wells Shawn D, Skwiat Tim M, et al.. International Society of Sports Nutrition Position Stand: protein and exercise. J Int Soc Sports Nutr. 2017;14:20.
    PMID 28642676 · PMC5477153 · doi:10.1186/s12970-017-0177-8
  63. Karmann Julia, Müller Benedikt, Hammes Ulrich Z. The long and winding road: transport pathways for amino acids in Arabidopsis seeds. Plant Reprod. 2018;31(3):253-261.
    PMID 29549431 · doi:10.1007/s00497-018-0334-5
  64. Katsanos Christos S, Kobayashi Hisamine, Sheffield-Moore Melinda, Aarsland Asle, Wolfe Robert R. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab. 2006;291(2):E381-7.
    PMID 16507602 · doi:10.1152/ajpendo.00488.2005
  65. Kerksick Chad M, Arent Shawn, Schoenfeld Brad J, Stout Jeffrey R, Campbell Bill, Wilborn Colin D, et al.. International society of sports nutrition position stand: nutrient timing. J Int Soc Sports Nutr. 2017;14:33.
    PMID 28919842 · PMC5596471 · doi:10.1186/s12970-017-0189-4
  66. Kim Mike, Wischmeyer Paul E. Glutamine. World Rev Nutr Diet. 2013;105:90-96.
    PMID 23075590 · doi:10.1159/000341276
  67. Klubo-Gwiezdzinska Joanna, Wartofsky Leonard. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol Arch Intern Med. 2022;132(3).
    PMID 35243857 · PMC9478900 · doi:10.20452/pamw.16222
  68. Kurpad Anura V, Regan Meredith M, Nazareth Dilip, Nagaraj Savita, Gnanou Justin, Young Vernon R. Intestinal parasites increase the dietary lysine requirement in chronically undernourished Indian men. Am J Clin Nutr. 2003;78(6):1145-51.
    PMID 14668277 · doi:10.1093/ajcn/78.6.1145
  69. Layman Donald K. Impacts of protein quantity and distribution on body composition. Front Nutr. 2024;11:1388986.
    PMID 38765819 · PMC11099237 · doi:10.3389/fnut.2024.1388986
  70. Levine Morgan E, Suarez Jorge A, Brandhorst Sebastian, Balasubramanian Priya, Cheng Chia-Wei, Madia Federica, et al.. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014;19(3):407-17.
    PMID 24606898 · PMC3988204 · doi:10.1016/j.cmet.2014.02.006
  71. Mamerow Madonna M, Mettler Joni A, English Kirk L, Casperson Shanon L, Arentson-Lantz Emily, Sheffield-Moore Melinda, et al.. Dietary protein distribution positively influences 24-h muscle protein synthesis in healthy adults. J Nutr. 2014;144(6):876-80.
    PMID 24477298 · PMC4018950 · doi:10.3945/jn.113.185280
  72. Martinho Diogo V, Nobari Hadi, Faria Ana, Field Adam, Duarte Daniel, Sarmento Hugo. Oral Branched-Chain Amino Acids Supplementation in Athletes: A Systematic Review. Nutrients. 2022;14(19).
    PMID 36235655 · PMC9571679 · doi:10.3390/nu14194002
  73. Mathai John K, Liu Yanhong, Stein Hans H. Values for digestible indispensable amino acid scores (DIAAS) for some dairy and plant proteins may better describe protein quality than values calculated using the concept for protein digestibility-corrected amino acid scores (PDCAAS). Br J Nutr. 2017;117(4):490-499.
    PMID 28382889 · doi:10.1017/S0007114517000125
  74. McKendry James, Coletta Giulia, Nunes Everson A, Lim Changhyun, Phillips Stuart M. Mitigating disuse-induced skeletal muscle atrophy in ageing: Resistance exercise as a critical countermeasure. Exp Physiol. 2024;109(10):1650-1662.
    PMID 39106083 · PMC11442788 · doi:10.1113/EP091937
  75. McLarney M J, Pellett P L, Young V R. Pattern of amino acid requirements in humans: an interspecies comparison using published amino acid requirement recommendations. J Nutr. 1996;126(7):1871-82.
    PMID 8683350 · doi:10.1093/jn/126.7.1871
  76. Mihaylova Maria M, Chaix Amandine, Delibegovic Mirela, Ramsey Jon J, Bass Joseph, Melkani Girish, et al.. When a calorie is not just a calorie: Diet quality and timing as mediators of metabolism and healthy aging. Cell Metab. 2023;35(7):1114-1131.
    PMID 37392742 · PMC10528391 · doi:10.1016/j.cmet.2023.06.008
  77. Miller Richard A, Harrison David E, Astle C Michael, Bogue Molly A, Brind Joel, Fernandez Elizabeth, et al.. Glycine supplementation extends lifespan of male and female mice. Aging Cell. 2019;18(3):e12953.
    PMID 30916479 · PMC6516426 · doi:10.1111/acel.12953
  78. Millward D J, Fereday A, Gibson N R, Pacy P J. Post-prandial protein metabolism. Baillieres Clin Endocrinol Metab. 1996;10(4):533-49.
    PMID 9022950 · doi:10.1016/s0950-351x(96)80696-3
  79. Millward D J. Human amino acid requirements. J Nutr. 1997;127(9):1842-6.
    PMID 9278570 · doi:10.1093/jn/127.9.1842
  80. Moore Daniel R, Robinson Meghann J, Fry Jessica L, Tang Jason E, Glover Elisa I, Wilkinson Sarah B, et al.. Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. Am J Clin Nutr. 2009;89(1):161-8.
    PMID 19056590 · doi:10.3945/ajcn.2008.26401
  81. Moore Daniel R, Churchward-Venne Tyler A, Witard Oliver, Breen Leigh, Burd Nicholas A, Tipton Kevin D, et al.. Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. J Gerontol A Biol Sci Med Sci. 2015;70(1):57-62.
    PMID 25056502 · doi:10.1093/gerona/glu103
  82. Mori H, Tokuda Y. De-Training Effects Following Leucine-Enriched Whey Protein Supplementation and Resistance Training in Older Adults with Sarcopenia: A Randomized Controlled Trial with 24 Weeks of Follow-Up. J Nutr Health Aging. 2022;26(11):994-1002.
    PMID 36437767 · doi:10.1007/s12603-022-1853-1
  83. Morley John E, Vellas Bruno, van Kan G Abellan, Anker Stefan D, Bauer Juergen M, Bernabei Roberto, et al.. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392-7.
    PMID 23764209 · PMC4084863 · doi:10.1016/j.jamda.2013.03.022
  84. Morton Robert W, Murphy Kevin T, McKellar Sean R, Schoenfeld Brad J, Henselmans Menno, Helms Eric, et al.. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384.
    PMID 28698222 · PMC5867436 · doi:10.1136/bjsports-2017-097608
  85. Morton Robert W, Murphy Kevin T, McKellar Sean R, Schoenfeld Brad J, Henselmans Menno, Helms Eric, et al.. Infographic. The effect of protein supplementation on resistance training-induced gains in muscle mass and strength. Br J Sports Med. 2019;53(24):1552.
    PMID 31227491 · doi:10.1136/bjsports-2019-100990
  86. O'Bryan Kerry R, Doering Thomas M, Morton Robert W, Coffey Vernon G, Phillips Stuart M, Cox Gregory R. Do multi-ingredient protein supplements augment resistance training-induced gains in skeletal muscle mass and strength? A systematic review and meta-analysis of 35 trials. Br J Sports Med. 2020;54(10):573-581.
    PMID 30824459 · doi:10.1136/bjsports-2018-099889
  87. Paddon-Jones Douglas, Campbell Wayne W, Jacques Paul F, Kritchevsky Stephen B, Moore Lynn L, Rodriguez Nancy R, et al.. Protein and healthy aging. Am J Clin Nutr. 2015;101(6):1339S-1345S.
    PMID 25926511 · doi:10.3945/ajcn.114.084061
  88. Paoletti Alyssa, Fakiha Abrar, Tul-Noor Zujaja, Pencharz Paul B, Levesque Crystal L, Ball Ronald O, et al.. Bioavailable Lysine Assessed Using the Indicator Amino Acid Oxidation Method in Healthy Young Males is High when Sorghum is Cooked by a Moist Cooking Method. J Nutr. 2022;152(3):770-778.
    PMID 34871427 · PMC8891180 · doi:10.1093/jn/nxab410
  89. Paoletti Alyssa, Courtney-Martin Glenda, Elango Rajavel. Determining amino acid requirements in humans. Front Nutr. 2024;11:1400719.
    PMID 39091679 · PMC11291443 · doi:10.3389/fnut.2024.1400719
  90. Pasiakos Stefan M, Cao Jay J, Margolis Lee M, Sauter Edward R, Whigham Leah D, McClung James P, et al.. Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB J. 2013;27(9):3837-47.
    PMID 23739654 · doi:10.1096/fj.13-230227
  91. Pencharz Paul B, Ball Ronald O. Amino acid requirements of infants and children. Nestle Nutr Workshop Ser Pediatr Program. 2006;58:109-16; discussion 116-9.
    PMID 16902329 · doi:10.1159/000095024
  92. Phillips Stuart M, Van Loon Luc J C. Dietary protein for athletes: from requirements to optimum adaptation. J Sports Sci. 2011;29 Suppl 1:S29-38.
    PMID 22150425 · doi:10.1080/02640414.2011.619204
  93. Pillai Raja R, Elango Rajavel, Muthayya Sumithra, Ball Ronald O, Kurpad Anura V, Pencharz Paul B. Lysine requirement of healthy, school-aged Indian children determined by the indicator amino acid oxidation technique. J Nutr. 2010;140(1):54-9.
    PMID 19923398 · doi:10.3945/jn.109.113357
  94. Plotkin Daniel L, Delcastillo Kenneth, Van Every Derrick W, Tipton Kevin D, Aragon Alan A, Schoenfeld Brad J. Isolated Leucine and Branched-Chain Amino Acid Supplementation for Enhancing Muscular Strength and Hypertrophy: A Narrative Review. Int J Sport Nutr Exerc Metab. 2021;31(3):292-301.
    PMID 33741748 · doi:10.1123/ijsnem.2020-0356
  95. Prado Carla M, Landi Francesco, Chew Samuel T H, Atherton Philip J, Molinger Jeroen, Ruck Tobias, et al.. Advances in muscle health and nutrition: A toolkit for healthcare professionals. Clin Nutr. 2022;41(10):2244-2263.
    PMID 36081299 · doi:10.1016/j.clnu.2022.07.041
  96. Rafii Mahroukh, Pencharz Paul B, Ball Ronald O, Tomlinson Christopher, Elango Rajavel, Courtney-Martin Glenda. Bioavailable Methionine Assessed Using the Indicator Amino Acid Oxidation Method Is Greater When Cooked Chickpeas and Steamed Rice Are Combined in Healthy Young Men. J Nutr. 2020;150(7):1834-1844.
    PMID 32271919 · doi:10.1093/jn/nxaa086
  97. Rafii Mahroukh, Pencharz Paul B, Boileau Kaylem, Ball Ronald O, Tomlinson Christopher, Elango Rajavel, et al.. Metabolic Availability of Methionine Assessed Using Indicator Amino Acid Oxidation Method, Is Greater when Cooked Lentils and Steamed Rice Are Combined in the Diet of Healthy Young Men. J Nutr. 2022;152(6):1467-1475.
    PMID 35218191 · doi:10.1093/jn/nxac049
  98. Rathmacher John A, Pitchford Lisa M, Stout Jeffrey R, Townsend Jeremy R, Jäger Ralf, Kreider Richard B, et al.. International society of sports nutrition position stand: β-hydroxy-β-methylbutyrate (HMB). J Int Soc Sports Nutr. 2025;22(1):2434734.
    PMID 39699070 · PMC11740297 · doi:10.1080/15502783.2024.2434734
  99. Richie J P, Sinha R, Dong Z, Nichenametla S N, Ables G P, Ciccarella A, et al.. Dietary Methionine and Total Sulfur Amino Acid Restriction in Healthy Adults. J Nutr Health Aging. 2023;27(2):111-123.
    PMID 36806866 · PMC10782544 · doi:10.1007/s12603-023-1883-3
  100. Rowlands David S, Nelson Andre R, Phillips Stuart M, Faulkner James A, Clarke Jim, Burd Nicholas A, et al.. Protein-leucine fed dose effects on muscle protein synthesis after endurance exercise. Med Sci Sports Exerc. 2015;47(3):547-55.
    PMID 25026454 · doi:10.1249/MSS.0000000000000447
  101. Salem Atef, Ben Maaoui Khouloud, Jahrami Haithem, AlMarzooqi Mezna A, Boukhris Omar, Messai Balsam, et al.. Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression. Sports Med Open. 2024;10(1):42.
    PMID 38625669 · PMC11021390 · doi:10.1186/s40798-024-00686-9
  102. Saxton Robert A, Knockenhauer Kevin E, Wolfson Rachel L, Chantranupong Lynne, Pacold Michael E, Wang Tim, et al.. Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science. 2016;351(6268):53-8.
    PMID 26586190 · PMC4698039 · doi:10.1126/science.aad2087
  103. Schaafsma Gertjan. Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br J Nutr. 2012;108 Suppl 2:S333-6.
    PMID 23107546 · doi:10.1017/S0007114512002541
  104. Schoenfeld Brad Jon, Aragon Alan, Wilborn Colin, Urbina Stacie L, Hayward Sara E, Krieger James. Pre- versus post-exercise protein intake has similar effects on muscular adaptations. PeerJ. 2017;5:e2825.
    PMID 28070459 · PMC5214805 · doi:10.7717/peerj.2825
  105. Schoenfeld Brad Jon, Aragon Alan Albert. Is There a Postworkout Anabolic Window of Opportunity for Nutrient Consumption? Clearing up Controversies. J Orthop Sports Phys Ther. 2018;48(12):911-914.
    PMID 30702982 · doi:10.2519/jospt.2018.0615
  106. Schwedhelm Edzard, Maas Renke, Freese Ralf, Jung Donald, Lukacs Zoltan, Jambrecina Alen, et al.. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65(1):51-9.
    PMID 17662090 · PMC2291275 · doi:10.1111/j.1365-2125.2007.02990.x
  107. Song Xiaoyun, Wang Huijun, Su Chang, Zhang Mei, Zhang Lei, Meng Jun, et al.. Distribution of daily protein intake and appendicular skeletal muscle mass in healthy free-living Chinese older adults. Eur J Nutr. 2024;63(5):1747-1757.
    PMID 38563983 · doi:10.1007/s00394-024-03364-4
  108. Szwiega Sylwia, Pencharz Paul B, Ball Ronald O, Xu Libai, Kong Dehan, Elango Rajavel, et al.. Length of Adaptation Has No Effect on the Threonine Requirement Determined in Healthy Young Adult Males Using the Indicator Amino Acid Oxidation Method. J Nutr. 2023;153(7):2016-2026.
    PMID 37004875 · doi:10.1016/j.tjnut.2023.03.033
  109. Szwiega Sylwia, Pencharz Paul B, Xu Libai, Kong Dehan, Tomlinson Christopher, Elango Rajavel, et al.. Leucine requirement determined in healthy young adult males using the indicator amino acid oxidation method. Am J Clin Nutr. 2024;120(5):1063-1070.
    PMID 39209155 · doi:10.1016/j.ajcnut.2024.08.022
  110. Tadié Jean-Marc, Locher Clara, Maamar Adel, Reignier Jean, Asfar Pierre, Commereuc Morgane, et al.. Enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients: the IMMUNOCITRE randomized clinical trial. Crit Care. 2023;27(1):381.
    PMID 37784110 · PMC10546668 · doi:10.1186/s13054-023-04651-y
  111. Tang Liyang, Angell Trevor E. Thyroid cancer. Semin Perinatol. 2025;49(2):152042.
    PMID 40089326 · doi:10.1016/j.semperi.2025.152042
  112. Tipton Kevin D. Nutritional Support for Exercise-Induced Injuries. Sports Med. 2015;45 Suppl 1:S93-104.
    PMID 26553492 · PMC4672013 · doi:10.1007/s40279-015-0398-4
  113. Trommelen Jorn, van Lieshout Glenn A A, Nyakayiru Jean, Holwerda Andrew M, Smeets Joey S J, Hendriks Floris K, et al.. The anabolic response to protein ingestion during recovery from exercise has no upper limit in magnitude and duration in vivo in humans. Cell Rep Med. 2023;4(12):101324.
    PMID 38118410 · PMC10772463 · doi:10.1016/j.xcrm.2023.101324
  114. Valenstein Max L, Rogala Kacper B, Lalgudi Pranav V, Brignole Edward J, Gu Xin, Saxton Robert A, et al.. Structure of the nutrient-sensing hub GATOR2. Nature. 2022;607(7919):610-616.
    PMID 35831510 · PMC9464592 · doi:10.1038/s41586-022-04939-z
  115. van Goudoever Johannes B, van der Schoor Sophie R D, Stoll Barbara, Burrin Douglas G, Wattimena Darcos, Schierbeek Henk, et al.. Intestinal amino acid metabolism in neonates. Nestle Nutr Workshop Ser Pediatr Program. 2006;58:95-102; discussion 102-8.
    PMID 16902328 · doi:10.1159/000095023
  116. van Vliet Stephan, Burd Nicholas A, van Loon Luc J C. The Skeletal Muscle Anabolic Response to Plant- versus Animal-Based Protein Consumption. J Nutr. 2015;145(9):1981-91.
    PMID 26224750 · doi:10.3945/jn.114.204305
  117. van Vliet Stephan, Shy Evan L, Abou Sawan Sidney, Beals Joseph W, West Daniel Wd, Skinner Sarah K, et al.. Consumption of whole eggs promotes greater stimulation of postexercise muscle protein synthesis than consumption of isonitrogenous amounts of egg whites in young men. Am J Clin Nutr. 2017;106(6):1401-1412.
    PMID 28978542 · doi:10.3945/ajcn.117.159855
  118. van Zanten Arthur Raymond Hubert, De Waele Elisabeth, Wischmeyer Paul Edmund. Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases. Crit Care. 2019;23(1):368.
    PMID 31752979 · PMC6873712 · doi:10.1186/s13054-019-2657-5
  119. Volpi E, Mittendorfer B, Wolf S E, Wolfe R R. Oral amino acids stimulate muscle protein anabolism in the elderly despite higher first-pass splanchnic extraction. Am J Physiol. 1999;277(3):E513-20.
    PMID 10484364 · doi:10.1152/ajpendo.1999.277.3.E513
  120. Voruganti V Saroja. Precision Nutrition: Recent Advances in Obesity. Physiology (Bethesda). 2023;38(1):0.
    PMID 36125787 · PMC9705019 · doi:10.1152/physiol.00014.2022
  121. Whittaker J L, Runhaar J, Bierma-Zeinstra S, Roos E M. A lifespan approach to osteoarthritis prevention. Osteoarthritis Cartilage. 2021;29(12):1638-1653.
    PMID 34560260 · doi:10.1016/j.joca.2021.06.015
  122. Witard Oliver C, Jackman Sarah R, Breen Leigh, Smith Kenneth, Selby Anna, Tipton Kevin D. Myofibrillar muscle protein synthesis rates subsequent to a meal in response to increasing doses of whey protein at rest and after resistance exercise. Am J Clin Nutr. 2014;99(1):86-95.
    PMID 24257722 · doi:10.3945/ajcn.112.055517
  123. Wolfe R R. Protein supplements and exercise. Am J Clin Nutr. 2000;72(2 Suppl):551S-7S.
    PMID 10919959 · doi:10.1093/ajcn/72.2.551S
  124. Wolfe Robert R. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality?. J Int Soc Sports Nutr. 2017;14:30.
    PMID 28852372 · PMC5568273 · doi:10.1186/s12970-017-0184-9
  125. Wolfe Robert R, Church David D, Ferrando Arny A, Moughan Paul J. Consideration of the role of protein quality in determining dietary protein recommendations. Front Nutr. 2024;11:1389664.
    PMID 39606577 · PMC11598328 · doi:10.3389/fnut.2024.1389664
  126. Wolfson Rachel L, Chantranupong Lynne, Saxton Robert A, Shen Kuang, Scaria Sonia M, Cantor Jason R, et al.. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science. 2016;351(6268):43-8.
    PMID 26449471 · PMC4698017 · doi:10.1126/science.aab2674
  127. Wu Guoyao. Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health. Amino Acids. 2020;52(3):329-360.
    PMID 32072297 · PMC7088015 · doi:10.1007/s00726-020-02823-6
  128. Xipsiti Maria. Protein quality evaluation: FAO perspective. Front Nutr. 2024;11:1446879.
    PMID 39698253 · PMC11654912 · doi:10.3389/fnut.2024.1446879
  129. Yates A A. National nutrition and public health policies: issues related to bioavailability of nutrients when developing dietary reference intakes. J Nutr. 2001;131(4 Suppl):1331S-4S.
    PMID 11285348 · doi:10.1093/jn/131.4.1331S
  130. Young V R, Marchini J S. Mechanisms and nutritional significance of metabolic responses to altered intakes of protein and amino acids, with reference to nutritional adaptation in humans. Am J Clin Nutr. 1990;51(2):270-89.
    PMID 2407099 · doi:10.1093/ajcn/51.2.270

27 Evidence handling

Study type is labelled in the reporting sentence. Animal and in-vitro results are never phrased as human outcomes. Acute MPS, mTOR phosphorylation, nitrogen balance, IAAO breakpoints, DIAAS scores, expert consensus, and hard clinical endpoints are treated as different objects. When a newer null trial and an older positive trial conflict, both are kept and the design reasons are named. Isolated-amino-acid trials that do not control total protein and energy are marked as inadequately controlled. Rodent longevity is labelled as rodent longevity.

Project 06 was queried read-only. Its current integration layer is rich in glutamine-and-cancer biochemistry and thin on human amino-acid nutrition trials; those 06 hits were used as orientation, not as the evidence base. 07_Peptide_News is a journalism/discovery layer and is not cited as scientific evidence. Full-text retrieval preferred PMC open access. Paywalled papers were used at metadata and abstract level when a verified identifier existed and the claim did not require a hidden table.

28 Limitations

This is a scientific article, not a systematic review with a registered protocol. Coverage is deep on muscle, requirements, protein quality, and the named controversies, and thinner on paediatric field nutrition and inborn errors of metabolism. Human ileal DIAAS data remain incomplete relative to pig data. Several official requirement numbers are still nitrogen-balance descendants. The literature was searched on 20 August 2026; later corrections and retractions after that date are not in the file.

Figures are original schematics. They are not measured mass-balances and not dosing charts. No third-party published figure has been reproduced.

29 Glossary

DIAAS. Digestible indispensable amino-acid score; ileal digestibility of individual IAA versus a reference pattern; not truncated at 1.0.

IAAO. Indicator amino-acid oxidation; a breakpoint method for estimating an indispensable-amino-acid requirement.

MPS / MPB. Muscle protein synthesis / breakdown; usually tracer-measured over hours.

PDCAAS. Protein digestibility-corrected amino-acid score; faecal digestibility; truncated at 1.0.

Splanchnic bed. Gut plus liver; the first-pass filter between a meal and the periphery.

Continue reading

Related science articles